<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cui, Xiaonan</style></author><author><style face="normal" font="default" size="100%">Liu, Houpu</style></author><author><style face="normal" font="default" size="100%">Zheng, Sunyi</style></author><author><style face="normal" font="default" size="100%">Wang, Hongwei</style></author><author><style face="normal" font="default" size="100%">Liu, Jiaxin</style></author><author><style face="normal" font="default" size="100%">Gao, Ziyi</style></author><author><style face="normal" font="default" size="100%">Liu, Tianye</style></author><author><style face="normal" font="default" size="100%">Liang, Jing</style></author><author><style face="normal" font="default" size="100%">Wang, Xiaoxu</style></author><author><style face="normal" font="default" size="100%">Zheng, Xinru</style></author><author><style face="normal" font="default" size="100%">Wang, Jing</style></author><author><style face="normal" font="default" size="100%">Bian, Keyi</style></author><author><style face="normal" font="default" size="100%">Yang, Xiaomeng</style></author><author><style face="normal" font="default" size="100%">Zhang, Chunlin</style></author><author><style face="normal" font="default" size="100%">Jiao, Tianshuo</style></author><author><style face="normal" font="default" size="100%">Yang, Yufei</style></author><author><style face="normal" font="default" size="100%">Fan, Shuxuan</style></author><author><style face="normal" font="default" size="100%">Wang, Xiuchao</style></author><author><style face="normal" font="default" size="100%">Gao, Song</style></author><author><style face="normal" font="default" size="100%">Gao, Chuntao</style></author><author><style face="normal" font="default" size="100%">Feng, Yukuan</style></author><author><style face="normal" font="default" size="100%">Li, Hui</style></author><author><style face="normal" font="default" size="100%">Xu, Guoping</style></author><author><style face="normal" font="default" size="100%">Zhang, Xiang</style></author><author><style face="normal" font="default" size="100%">Shen, Wen</style></author><author><style face="normal" font="default" size="100%">Sun, Haoran</style></author><author><style face="normal" font="default" size="100%">Sun, Baocun</style></author><author><style face="normal" font="default" size="100%">Sun, Yan</style></author><author><style face="normal" font="default" size="100%">Xiao, Jianyu</style></author><author><style face="normal" font="default" size="100%">Zheng, Yalin</style></author><author><style face="normal" font="default" size="100%">Ying, Michael</style></author><author><style face="normal" font="default" size="100%">de Bock, Geertruida H.</style></author><author><style face="normal" font="default" size="100%">Ye, Zhaoxiang</style></author><author><style face="normal" font="default" size="100%">Hao, Jihui</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">An integrated CT/MRI diagnostic system for pancreatic cystic lesions that supports pathological classification and risk stratification</style></title><secondary-title><style face="normal" font="default" size="100%">Cancer Biology &amp;amp; Medicine</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2026</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2026-10-15 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">1495-1512</style></pages><doi><style  face="normal" font="default" size="100%">10.20892/j.issn.2095-3941.2026.0566</style></doi><volume><style face="normal" font="default" size="100%">23</style></volume><issue><style face="normal" font="default" size="100%">10</style></issue><abstract><style  face="normal" font="default" size="100%">Objective: To develop a pathology-based preoperative decision-support system (Structured Imaging Report System for Pancreatic Cystic Lesions, SIRS-PCL) for subtype classification and risk stratification of PCLs.Methods: We conducted a multicentre retrospective study involving 1,102 patients treated between 1 January 2011 and 31 December 2024. The study cohort was divided into a development dataset (n = 858) and a temporal validation dataset (n = 244) from the periods 2011–2022 and 2023–2024, respectively. Three logistic prediction models were used to classify the five PCL subtypes and to perform separate three-tier risk stratifications (benign/low, medium, and high) for intraductal papillary mucinous neoplasm (IPMN) and mucinous cystic neoplasm (MCN) cases. SIRS-PCL was prospectively implemented at Tianjin Medical University Cancer Institute and Hospital from 25 June 2025 to 25 June 2026, and the diagnostic accuracy, sensitivity, and specificity were evaluated in a cohort of 76 patients.Results: A total of 1,102 patients with PCLs were included in the study (median age 56 years, interquartile range 44–64), of whom 714 were female (64.8%). The five-category model included in SIRS-PCL achieved a mean area under the receiver operating characteristic curve (AUC) of 0.93 [95% confidence interval (CI) 0.91–0.95] in temporal validation. The IPMN model showed good discrimination for risk stratification (mean AUC 0.86, 95% CI 0.79–0.93), with the highest overall accuracy of 77.1% exceeding current guidelines (range 50.0%–58.6%). The MCN risk model also showed high performance (mean AUC 0.97, 95% CI 0.91–1.00). In comparison to current practice, SIRS-PCL use reduced unnecessary surgeries 11.5% vs. 23.1% and over-examinations 6.7% vs 33.7%. In the prospective implementation cohort, SIRS-PCL achieved accuracy of 86.2% for five-category pathological classification, 73.7% for IPMN risk stratification, and 100% for MCN risk stratification.Conclusions: SIRS-PCL is a pathology-based, quantitative decision-support system for preoperative pathological subtype classification and pathological risk stratification of surgically evaluated neoplastic PCLs.SIRS-PCL is publicly accessible at https://sirs-pcl.tjmucih.cn:16433/. For demonstration and system testing, we have provided a test account (Username: TEST; Password: Test1234@). The source code generated in this study is publicly available in the SIRS-PCL GitHub repository at https://github.com/MAGIC-LAB-TJMUCH/Development-of-SIRS-PCL.git.</style></abstract></record></records></xml>